Efficacy and economics of postoperative blood salvage in patients undergoing elective total hip replacement

Annals of the Royal College of Surgeons of England

Volumn 89, Issue 8, 2007, Pages 777-784

  Mirza, Saqeb B ^a   Campion, Jon ^a   Dixon, John H ^a   Panesar, Sukhmeet S ^b  

^a WESTON GENERAL HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Blood salvage; Hip replacement; Transfusion

Indexed keywords

ANTIBIOTIC AGENT; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; COST OF ILLNESS; ECONOMIC EVALUATION; ELECTIVE SURGERY; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; THROMBOSIS; TOTAL HIP PROSTHESIS;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION, AUTOLOGOUS; CLINICAL PROTOCOLS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; POSTOPERATIVE CARE; SURGICAL PROCEDURES, ELECTIVE;

EID: 36648999795     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588407X209310     Document Type: Article

References (56)

1. Marx RG, Wotherspoon S, Stephens D, Davey JR. Patient factors affecting autologous and allogeneic blood transfusion rates in total hip arthroplasty. Am J Orthop 2001; 30: 867-71.
2. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
3. Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO. Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty 1995; 10: 532-9.
4. Keating EM, Ritter MA. Transfusion options in total joint arthroplasty. J Arthroplasty 2002; 17: 125-8.
5. Regan F, Taylor C. Blood transfusion medicine. BMJ 2002; 325: 143-7.
6. Rosenblatt MA. Strategies for minimizing the use of allogeneic blood during orthopedic surgery. Mt Sinai J Med 2002; 69: 83-7.
7. Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ 2002; 324: 772-5.
8. Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells. J Bone Joint Surg Am 1991; 73: 1169-78.
9. Robbins G, Grech H, Howes K. A study of autologous blood collected after joint replacement surgery. Vox Sang 1992; 62: 152-5.
10. Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop 1994; 299: 53-9.
11. Jensen CM, Pilegaard R, Hviid K, Nielsen JD, Nielsen HJ. Quality of reinfused drainage blood after total knee arthroplasty. J Arthroplasty 1999; 14: 312-8.
12. Grosvenor D, Goyal V, Goodman S. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg Am 2000; 82: 951-4.
13. Ayers DC, Murray DG, Duerr DM. Blood salvage after total hip arthroplasty. J Bone Joint Surg Am 1995; 77: 1347-51.
14. Gannon DM, Lombardi Jr AV, Mallory TH, Vaughn BK, Finney CR, Niemcryk S. An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial. J Arthroplasty 1991; 6: 109-14.
15. Friederichs MG, Mariani EM, Bourne MH. Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty. J Arthroplasty 2002; 17: 298-303.
16. The Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. Transfus Med 1994; 4: 251-68.
17. Spencer J, Thomas SR, Yardy G, Mukundan C, Barrington R. Are we overusing blood transfusing after elective joint replacement? - a simple method to reduce the use of a scarce resource. Ann R Coll Surg Engl 2005; 87: 28-30.
18. Oxford Blood Centre. Comparative audit of the use of red cell transfusion of patients undergoing primary total hip replacement in hospitals served by the Oxford Region. Oxford: Oxford Blood Centre, 2000.
19. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999; 81: 1580-8.
20. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003; 31: 529-37.
21. Harley BJ, Beaupre LA, Jones CA, Cinats JG, Guenther CR. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 2002; 45: 185-90.
22. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoetin Study Group. J Bone Joint Surg Am 1996; 78: 62-72.
23. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
24. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-24.
25. Wynn Jones H, Savage L, White C, Goddard R, Lumley H, Kashif F et al. Postoperative autologous blood salvage drains - Are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases. Acta Orthop Belg 2004; 70: 466-73.
26. Guerra JJ, Cuckler JM. Cost effectiveness of intraoperative autotransfusion in total hip arthroplasty surgery. Clin Orthop 1995; 315: 212-22.
27. Groh GI, Buchert PK, Allen WC. A comparison of transfusion requirements after total knee arthroplasty, using the Solcotrans autotransfusion system. J Arthroplasty 1990; 5: 281-5.
28. Strumper D, Weber EW, Gielen-Wijffels S, Van Drumpt R, Bulstra S, Slappendel R et al. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 2004; 44: 1567-71.
29. Wojan M, Scholz R, Salis-Soglio G, Schmidt M, Wild A. [Retransfusion of unwashed drainage blood after total hip and knee arthroplasty]. Biomed Tech (Berl) 2005; 50: 355-60.
30. Rossner S. [Autotransfusion in prosthetic hip surgery]. Tidsskr Nor Laegeforen 2006; 126: 1328-9.
31. Hays MB, Mayfield JF. Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations. J Arthroplasty 1988; 3 (Suppl): S47-9.
32. Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A et al. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg 1995; 161: 487-92.
33. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol 2000; 17: 411-7.
34. Steinitz D, Harvey EJ, Leighton RK, Petrie DP. Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg 2001; 44: 355-8.
35. Reize P, Endele D, Rudert M, Wulker N. [Postoperative autologous transfusion from blood drainage after total hip joint arthroplasty - how much value is really there?]. Z Orthop lhre Grenzgeb 2006; 144: 400-4.
36. Cregan P, Donegan E, Gotelli G. Hemolytic transfusion reaction following transfusion of frozen and washed autologous red cells. Transfusion 1991; 31: 172-5.
37. Baussaud V, Mentec H, Fourcade C. Hemolysis after autologous transfusion. Ann Intern Med 1996; 124: 931-2.
38. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion 1998; 38: 296-300.
39. Arnestad JP, Bengtsson A, Bengtson JP, Tylman M, Redl H, Schlag G. Formation of cytokines by retransfusion of shed whole blood. Br J Anaesth 1994; 72: 422-5.
40. Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A. Greater increase in cytokine concentration after salvage with filtered whole blood than with washed red cells, but no difference in postoperative hemoglobin recovery. Transfusion 1999; 39: 271-6.
41. Bengtsson A, Avail A, Hyllner M, Bengtson JP. Formation of complement split products and proinflammatory cytokines by reinfusion of shed autologous blood. Toxicol Lett 1998; 100/101: 129-33.
42. Southern EP, Huo MH, Mehta JR, Keggi KJ. Unwashed wound drainage blood. What are we giving our patients? Clin Orthop 1995; 320: 235-46.
43. Andersson I, Tylman M, Bengtson JP, Bengtsson A. Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can J Anaesth 2001; 48: 251-5.
44. Krohn CD, Reikeras O, Bjornsen S, Brosstad F. Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery. Eur J Surg 2001; 167: 168-72.
45. Blevins FT, Shaw B, Valeri CR, Kasser J, Hall J. Reinfusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg Am 1993; 75: 363-71.
46. Bengtson JP, Backman L, Stenqvist O, Heideman M, Bengtsson A. Complement activation and reinfusion of wound drainage blood. Anesthesiology 1990; 73: 376-80.
47. Dalen T, Nilsson KG, Engstrom KG. Fever and autologous blood retransfusion after total knee arthroplasty: a prospective study of 40 autotransfusion events in 21 patients. Acta Orthop Scand 2002; 73: 321-5.
48. Sinardi D, Marino A, Chillemi S, Irrera M, Labruto G, Mondello E. Composition of the blood sampled from surgical drainage after joint arthroplasty: quality of return. Transfusion 2005; 45: 202-7.
49. Handel M, Winkler J, Homlein RF, Northoff H, Heeg P, Sell S. Time-related changes of collected shed blood in autologous retransfusion after total knee arthroplasty. Arch Orthop Trauma Surg 2001; 121: 557-60.
50. Simpson MB, Murphy KP, Chambers HG, Bucknell AL. The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics 1994; 17: 133-7.
51. Krohn CD, Reikeras O, Bjornsen S, Brosstad F. Fibrinogen, fibrin and its degradation products in drained blood after major orthopaedic surgery. Blood Coagul Fibrinolysis 1999; 10: 167-71.
52. Umlas J, Jacobson MS, Kevy SV. Survival and half-life of red cells salvaged after hip and knee replacement surgery. Transfusion 1993; 33: 591-3.
53. Sebastian C, Romero R, Olalla E, Ferrer C, Garcia-Vallejo JJ, Munoz M. Postoperative blood salvage and reinfusion in spinal surgery: blood quality, effectiveness and impact on patient blood parameters. Eur Spine J 2000; 9: 458-65.
54. Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stockl B et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39: 625-32.
55. Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. J Bone Joint Surg Br 1997; 79: 630-2.
56. Martin JW, Whiteside LA, Milliano MT, Reedy ME. Postoperative blood retrieval and transfusion in cementless total knee arthroplasty. J Arthroplasty 1992; 7: 205-10.